tiprankstipranks
Trending News
More News >
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PremiumThe FlyCisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
1M ago
CytomX Therapeutics price target raised to $5 from $2.50 at Piper Sandler
Premium
The Fly
CytomX Therapeutics price target raised to $5 from $2.50 at Piper Sandler
1M ago
Promising Clinical Data and Safety Profile Lead to Buy Rating for CytomX Therapeutics’ CX-2051
Premium
Ratings
Promising Clinical Data and Safety Profile Lead to Buy Rating for CytomX Therapeutics’ CX-2051
1M ago
CytomX Therapeutics Reports Q1 2025 Results and Progress
PremiumCompany AnnouncementsCytomX Therapeutics Reports Q1 2025 Results and Progress
1M ago
CytomX Therapeutics 76.9M share Secondary priced at $1.30
Premium
The Fly
CytomX Therapeutics 76.9M share Secondary priced at $1.30
1M ago
CytomX Therapeutics Reports Positive Interim Phase 1 Data
Premium
Company Announcements
CytomX Therapeutics Reports Positive Interim Phase 1 Data
1M ago
CytomX Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyCytomX Therapeutics participates in a conference call with JPMorgan
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability
Premium
Company Announcements
CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100